Live
Home·Deals·pharmaceuticals·Sun Pharma acquires Organon
Sun Pharma acquires Organon (2026)
SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-8
acquisitionAnnounced · Jan 31, 2026pharmaceuticalsSource · CredibleArticle · Factual
Organon
Sun Pharma
Organon · Sun Pharma

Sun Pharma acquires Organon

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$10B
Target
Organon
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Sun Pharma
Full Acquisition
Status
Pending

Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.

This page summarizes publicly available information about the transaction as of 2026-01-31. Figures and status may change as filings and press coverage update.

Abhijeet Singh ET Pharma Updated On Jan 31, 2026 at 10:20 PM IST New Delhi: Amid speculation” of making a potential bid to acquire US-based Organon for an enterprise value of $10–14 billion , Sun Pharma Founder and Executive Chairman Dilip Shanghvi said the company wants to remain disciplined in its acquisition strategy

Deal timeline

Announced
Jan 31, 2026 · pharma.economictimes.indiatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.

Sources: pharma.economictimes.indiatimes.com · Primary article · FireStrike proprietary index